“달서핸플👧 ≤OPDAL040.COM≥오피달리기 ⛄️달서OP🙂달서풀싸롱🈸달서아로마🌑달서OP🚎달서스웨디시🎿달서키스방👧”的搜索结果,显示 191-200 项,共有 15582 项
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...
This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal ...
... ≥ 60ml/min). Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer. Jacksonville, Fla., Rochester, Minn., Scottsdale ...
This clinical trial evaluates the safety and feasibility of tumor treating fields (TTF) in the treatment of spinal leptomeningeal disease in patients with ...
Jacksonville, Fla. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with bendamustine plus MabThera/Rituxan ( ...
We aim to recruit 100 subjects (50 survivors and 50 caregivers) to the study. Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including ...
The objective of this study is to collect tumor specimens (tumor tissues, matched normal tissue when possible, and 50 mL of blood) that may inform cancer ...
In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...
Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...
皮质类固醇药物用于治疗类风湿关节炎、炎性肠病(IBD)、哮喘、过敏及其他诸多病症。这类药物也可用于防止器官移植受体出现器官排斥反应,即通过帮助抑制免疫系统来实现。
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊,和我们一起进行尖端研究和医护,共同推动医学的改变。